Published in Circ Res on April 01, 1968
Measurement of peak rates of left ventricular wall movement in man. Comparison of echocardiography with angiography. Br Heart J (1975) 1.81
Estimation of Vmax in auxotonic systoles from the rate of relative increase of isovolumic pressure: (dP-dt)kP. J Clin Invest (1971) 0.98
The demonstration of alternating contractile state in pulsus alternans. J Clin Invest (1970) 0.93
The maximum derivatives of left ventricular pressure and transverse internal diameter as indices of the inotropic state of the left ventricle in conscious dogs. J Physiol (1973) 0.91
Quantitative angiographic analysis of the left ventricle in patients with isolated rheumatic mitral stenosis. Br Heart J (1973) 0.90
Ejection phase indices of left ventricular performance in infants, children, and adults. Br Heart J (1975) 0.89
Role of tachycardia as an inotropic stimulus in man. J Clin Invest (1979) 0.85
Usefulness and limitations of circumferential fibre shortening velocity in evaluating segmental disorders of left ventricular contraction. Br Heart J (1974) 0.85
Haemodynamic effects of angiographic contrast material in man. A beat-by-beat analysis. Br Heart J (1972) 0.84
Noninvasive study of effect of isometric exercise on left ventricular performance in normal man. Br Heart J (1974) 0.83
Angiographic assessment of left ventricular function in patients with ischaemic heart disease without clinical heart failure. Br Heart J (1971) 0.79
Cardiac performance in hypertension re-evaluated through a combined haemodynamic ultrasonic method. Br Heart J (1980) 0.78
The apexcardiogram in ischemic heart disease. Calif Med (1972) 0.78
Model for left ventricular contraction combining the force length velocity relationship with the time varying elastance theory. Biophys J (1984) 0.76
Force generation and shortening capabilities of left ventricular myocardium in primary and secondary forms of mitral regurgitation. Br Heart J (1969) 0.75
Source parameters of the left ventricle related to the physiological characteristics of the cardiac muscle. Biophys J (1986) 0.75
Clinical studies concerning the determinants of myocardial 201Thallium uptake. Basic Res Cardiol (1978) 0.75
Diastolic aortic pressure rise during percutaneous transluminal coronary angioplasty: an index of left ventricular systolic dysfunction. Br Heart J (1995) 0.75
Evidence for non-infiltrative cardiomyopathy in acute leukaemia and lymphoma. A clinical and echocardiographic study. Br Heart J (1978) 0.75
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA (2000) 12.86
Stochastic kinetic analysis of developmental pathway bifurcation in phage lambda-infected Escherichia coli cells. Genetics (1998) 12.21
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation (1990) 9.74
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med (2001) 9.31
In vitro synthesis of DNA complementary to purified rabbit globin mRNA (RNA-dependent DNA polymerase-reticulocyte-hemoglobin-density gradient centrifugation-oligo(dT) primer). Proc Natl Acad Sci U S A (1972) 7.89
Factors influencing infarct size following experimental coronary artery occlusions. Circulation (1971) 7.04
Fiber orientation in the canine left ventricle during diastole and systole. Circ Res (1969) 7.01
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med (1996) 6.92
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A (1991) 5.60
The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation (1982) 5.56
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med (2001) 5.50
A precursor of globin messenger RNA. J Mol Biol (1976) 5.34
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation (2000) 5.15
Phenological changes reflect climate change in Wisconsin. Proc Natl Acad Sci U S A (1999) 4.99
MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell (1997) 4.67
TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation (1996) 4.41
Myocardial infarct size and ventricular function in rats. Circ Res (1979) 4.33
Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest (1965) 4.23
Myocardial reperfusion: a double-edged sword? J Clin Invest (1985) 4.12
Globin messenger-RNA induction during erythroid differentiation of cultured leukemia cells. Proc Natl Acad Sci U S A (1972) 4.02
A trial of two strategies to modify the test-ordering behavior of medical residents. N Engl J Med (1980) 3.98
Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol (1988) 3.96
Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res (1966) 3.95
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1999) 3.90
Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation (1968) 3.82
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem (1998) 3.80
Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell (1999) 3.76
Separation of murine cellular and murine leukaemia virus DNA polymerases. Nat New Biol (1971) 3.71
The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol Cell Biol (1989) 3.69
Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol (1971) 3.68
Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis (1995) 3.66
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation (2000) 3.66
Aortic stenosis. Circulation (1968) 3.49
Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42
Cyclosporine-associated chronic nephropathy. N Engl J Med (1984) 3.39
Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation (1996) 3.34
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med (1971) 3.24
Mean velocity of fiber shortening. A simplified measure of left ventricular myocardial contractility. Circulation (1971) 3.19
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell (2001) 3.13
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet (2009) 3.13
Long term acid suppressing treatment in general practice. BMJ (1994) 3.11
Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet (2001) 3.07
Selective suppression of the magnocellular visual pathway during saccadic eye movements. Nature (1994) 3.00
Mechanism of action of calcium-channel-blocking agents. N Engl J Med (1982) 2.99
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med (1988) 2.98
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol (2004) 2.95
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation (2000) 2.93
Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev (1992) 2.90
Poly(A), poly(A) binding protein and the regulation of mRNA stability. Trends Biochem Sci (1989) 2.78
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet (2001) 2.78
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A (2001) 2.77
Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A (1998) 2.76
Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol (1982) 2.73
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. N Engl J Med (1992) 2.72
Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell (1999) 2.68
Immunological relationships of reverse transcriptases from ribonucleic acid tumor viruses. J Virol (1972) 2.65
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation (1997) 2.64
H4 histone messenger RNA decay in cell-free extracts initiates at or near the 3' terminus and proceeds 3' to 5'. J Mol Biol (1986) 2.63
Regulation of mRNA turnover in eukaryotic cells. Crit Rev Eukaryot Gene Expr (1991) 2.62
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation (1999) 2.59
Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog. Circ Res (1974) 2.57
Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J Clin Invest (1967) 2.51
A review and meta-analysis of the patient factors associated with psychiatric in-patient aggression. Acta Psychiatr Scand (2013) 2.48
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med (1998) 2.43
Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol (1988) 2.42
Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol (1991) 2.40
Estimation of VO2max from a one-mile track walk, gender, age, and body weight. Med Sci Sports Exerc (1987) 2.34
Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol Cell Biol (1989) 2.33
Skeletal repair by in situ formation of the mineral phase of bone. Science (1995) 2.33
Unstable angina: an etiologic approach to management. Circulation (1998) 2.31
The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm. Circulation (1965) 2.30
Oxygen consumption of the heart. Newer concepts of its multifactoral determination. Am J Cardiol (1968) 2.29
Coronary-artery surgery at the crossroads. N Engl J Med (1977) 2.28
Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest (1973) 2.28
Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J (2001) 2.28
Globin gene expression in cultured erythroleukemic cells. J Mol Biol (1974) 2.28
Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem (1995) 2.27
Precursors of alpha and beta globin messenger RNAs. J Mol Biol (1978) 2.26
Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res (1985) 2.23
Presentation with influenza-like illness in general practice: implications for use of neuraminidase inhibitors. Commun Dis Public Health (2000) 2.22
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
The precursor of mouse beta-globin messenger RNA contains two intervening RNA sequences. Cell (1978) 2.21
Coronary-artery spasm. N Engl J Med (1978) 2.20